Karachi: Citi Pharma Ltd., a prominent player in the pharmaceuticals sector, has recently disclosed a series of share transfers involving key stakeholders, as mandated by PSX Regulation 5.6.4. These transactions, recorded on April 15, 2025, have drawn significant attention in the market due to their substantial volume.

The disclosure reports several individuals receiving shares as gifts through the Central Depository Company (CDC). According to the released data, Ateeq Ur Rehman received a total of 1,318,268 shares in a transaction marked with a zero-rate value. Similarly, Naveed Amjad was gifted 659,134 shares under the same conditions. Saima Usman and Misbah Tahir each received an additional 329,567 shares.

In a more substantial transfer, Saad Bin Nadeem was gifted 22.85 million shares. Furthermore, Saima Usman and Misbah Tahir were recipients of an additional 2.7 million shares each.

According to information available from the Pakistan Stock Exchange (PSX), these transactions are compliant with existing regulatory frameworks, ensuring transparency and accountability in the market. The total volume of shares transferred in these transactions amounts to 30.89 million.

The pharmaceuticals sector is closely monitoring these developments, as such significant share movements could potentially impact market dynamics and investor strategies.